Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/4/2025

Pharmacotherapy for PTSD

First-Line Treatment

  • The American Academy of Sleep Medicine recommends SSRIs as the established first-line pharmacological treatment for PTSD, with sertraline and paroxetine holding FDA approval for this indication 1
  • Response rates with SSRIs reach 53-85% in clinical trials, significantly outperforming placebo (32-62%) 1

SNRIs as Second-Line Treatment

  • SNRIs have demonstrated efficacy in other anxiety disorders and chronic pain conditions, which provides indirect support for their use in PTSD 2
  • In anxiety disorders more broadly, SNRIs show comparable efficacy to SSRIs with similar response rates and dropout rates, according to the American College of Neuropsychopharmacology 3

Treatment Algorithm for PTSD Pharmacotherapy

  • For partial responders, consider adding atypical antipsychotics (risperidone has strongest evidence) or prazosin for nightmares, as recommended by the American Academy of Sleep Medicine 4

Critical Safety Considerations for SNRIs

  • Monitor blood pressure and pulse regularly, as SNRIs are associated with sustained hypertension and increased pulse, according to the American College of Cardiology 3
  • Never discontinue SNRIs abruptly—require slow taper due to significant discontinuation syndrome, particularly with venlafaxine, as recommended by the American Psychiatric Association 3

Duration of Treatment

  • Relapse rates are higher with medication discontinuation (26-52% for sertraline) compared to completion of cognitive behavioral therapy, according to the American Psychological Association 1

REFERENCES

3

SNRI as Adjunct Therapy for Anxiety [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

best practice guide for the treatment of nightmare disorder in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010